NCT06532175

Brief Summary

The aim of this clinical trial is to determine the effects of su jok seed therapy on pain, anxiety and psychological resilience in patients hospitalized in the oncology ward. This study seeks answers to the following questions; Does su jok seed therapy affect the pain levels of cancer patients? Does su jok seed therapy affect the anxiety levels of cancer patients? Does su jok seed therapy affect the Psychological resilience levels of cancer patients? There will be an experimental and control group in the study and the effectiveness of sujok application will be examined. A total of 8 sessions of su jok seed therapy will be applied to the experimental group, twice a week for a month. No intervention will be made to the control group. Individuals over 18 years old, without communication problems and diagnosed with cancer will be included in the sample.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable cancer

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

August 1, 2024

Status Verified

July 1, 2024

Enrollment Period

Same day

First QC Date

July 29, 2024

Last Update Submit

July 29, 2024

Conditions

Keywords

su-jokcancer patientsanxietypainPsychological resilience

Outcome Measures

Primary Outcomes (3)

  • Pain levels of cancer patients will be evaluated using VAS.

    Pain levels of cancer patients

    2 months

  • Anxiety levels of cancer patients will be evaluated using the "State Anxiety Scale".

    Anxiety levels of cancer patients

    2 months

  • Psychological resilience levels of cancer patients will be evaluated using the "Brief Psychological Resilience Scale".

    Psychological resilience levels of cancer patients

    2 months

Study Arms (2)

Su-jok Therapy Group /EXPERIMENTAL GROUP

EXPERIMENTAL

Providing a comfortable position considering the individual's limitations. In order for the hands not to be cold, the researcher will warm them by rubbing them together and will plan to grasp the patient's hand. The individuals' pain areas will be determined and reflection points corresponding to these areas on the yin and yang sides will be determined. The individual will be asked to state when they experience pain and pulling sensations at the points touched by the applicator. Determining painful reflection points on the back of the individual's hand When each reflection point is determined, green mung bean will be placed on the relevant point and fixed with a plaster band. The same procedure will be applied to all painful points until the individual states that there are no more painful points The point where the seed is fixed will be massaged for 30 minutes. The individual will be helped to take a comfortable position.

Device: Su-Jok

Control Group

NO INTERVENTION

No intervention will be made. Data will only be collected when the participant participates in the study, one month after participating in the study, and 2 months after participating in the study.

Interventions

Su-JokDEVICE

Su-jok seed therapy

Also known as: Su-jok seed therapy
Su-jok Therapy Group /EXPERIMENTAL GROUP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being over 18 years old,
  • No communication problems,
  • Individuals diagnosed with cancer

You may not qualify if:

  • Getting worse or dying during the research process

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

NeoplasmsCancer PainAnxiety DisordersPain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Central Study Contacts

Güzel Nur YILDIZ, Dr.

CONTACT

Arzu KARAKAYA, Specialist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2024

First Posted

August 1, 2024

Study Start

August 1, 2024

Primary Completion

August 1, 2024

Study Completion

October 1, 2024

Last Updated

August 1, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share